Professional Experience: Auditor at Peat, Marwick, Mitchell & Co. Controller of a small manufacturing company, a division of U S Industries. Director of Business Planning at Esmark, Inc. Position included strategic planning, competitor comparisons, and analysis of potential acquisitions. CFO of a Fortune 500 company, Envirodyne Industries, Inc., which was sold in 1989 for $ 40/share vs $ 1/share (approximately) when I joined the company in 1984. Envirodyne grew threw internal growth and acquisitions. Our management team was skillful and, quite frankly, many variables beyond our control turned out favorably for us. Adjunct professor teaching Accounting I and II, Investments and Personal Finance courses at Benedictine University in Lisle, IL Now semi-retired, actively manage my own portfolio. Tutor math and teach religious education at local schools. My portfolio was devastated during the 2008-09 crisis, but has partially rebounded since then--my portfolio is more conservative these days. I totally ignored the warning signs back then. I am more open now to weighing and considering more extreme scenarios that I would have ignored before the most recent crisis. NOT a stock broker nor in any way registered with the S.E.C. I am strictly a private investor. Earned BS in BA from John Carroll University, Cleveland, OH. Earned Masters in Accounting from Ohio State University in Columbus, OH.
I am projecting that the US govt is near insolvent and that we will be facing a new Bretton Woods currency agreement bringing gold back into the monetary system in combination with a sudden fiat currency devaluation (across the board-most currencies) against gold over a long weekend or an outright sovereign debt panic by 2015-2016. The least expected outcome double digit inflation is very likey in the future. The Fed PRO-POVERTY policies are going to crush the poor, fixed pensioners and lower middle class since disposable income growth is limited. Beware middle class and retirees your purchasing power will drop dramatically when everyday necessities absorb a larger % of your income.
To spread the word to the brainwashed American drones that this economy is one big illusion ponzi scheme and you are infact broke.
Issuing more debt to solve a debt problem is crazy.
I am accepting nominations for those that played a major positive and major negative impact on our economy.
The Hammer Hall of Fame
The Hammer Hall of Shame
Ben MadMan Bernanke
Alan "The Maestro" Greenspan
Paul king Krugman
I have a diverse background—as a financial journalist, resident physician, mixed martial artist, painter, entrepreneur, chemistry instructor and web developer—that enabled me to pioneer the “Integrated Investing Research” approach.
I provide consulting to clients, both the retail and professional investors. I accurately forecasted many clinical trials, such as the Flint Trials for Intercept, the Ascend Trials for InterMune and the Affinity Trials MannKind, just to name a few. Through Vincata Enterprises, LLC, I helped many clients to unlock substantial values for their investments.
As an expert in biopharmaceutical analysis, I am also more than capable of analyzing any other industries. Though not shown on Seeking Alpha, I have picked an aggregate basket of outperforming stocks.
Investing in biotech is highly risky, but it can be quite rewarding when investors have an edge in data analysis. Physicians who are rigidly scientific tend to lack the analytical prowess of financial experts. Conversely, financiers usually do not possess a physician’s medical expertise. Likewise, scientists are skillful in data analysis; yet they might not be familiar with a physician’s prescribing patterns, which is a requisite to successful biotech investing.
You can visit my website at https://www.retailinvestor360.com for business inquiry.
I spent many years as an executive in corporate America, but I have always been an investor focused on long term investment in promising small cap companies. Now I spend most of my time reading about stocks and investing in small cap companies